Hospital News and Research

RSS
Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

Guardian Home Care Holdings, Cardiocom provide home telehealth technology to patients with chronic illnesses

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

University Hospitals of Morecambe Bay NHS Trust implements Lorenzo Regional Care Release 1.9

MKMG implements CoActiv Medical's EXAM-VAULT QUAD-REDUNDANT ARCHIVING solution

MKMG implements CoActiv Medical's EXAM-VAULT QUAD-REDUNDANT ARCHIVING solution

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

Baylor Health Care System opens new Diabetes Health and Wellness Institute in South Dallas

Clinical trial data of imetelstat in patients with breast cancer presented at ASCO annual meeting

Clinical trial data of imetelstat in patients with breast cancer presented at ASCO annual meeting

SCCT names finalists of fourth annual Young Investigator Award

SCCT names finalists of fourth annual Young Investigator Award

Pharmacoeconomic methods influence only 13% of hospital formulary system decisions: Survey

Pharmacoeconomic methods influence only 13% of hospital formulary system decisions: Survey

Strained relationship with parents following stroke increases depression in daughters: Study

Strained relationship with parents following stroke increases depression in daughters: Study

Bevacizumab extends progression-free survival in women with advanced ovarian cancer

Bevacizumab extends progression-free survival in women with advanced ovarian cancer

Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients

Chemotherapy delivered directly into liver blood vessels increases progression-free survival in melanoma patients

The Iacocca Family Foundation and Kineta partner to develop Type 1 diabetes mellitus drug

The Iacocca Family Foundation and Kineta partner to develop Type 1 diabetes mellitus drug

Eisai's eribulin mesylate improves median OS compared with TPC in pre-treated metastatic breast cancer patients

Eisai's eribulin mesylate improves median OS compared with TPC in pre-treated metastatic breast cancer patients

Bisphosphonates may cause poorer survival rate in women with early stage breast cancer: Study

Bisphosphonates may cause poorer survival rate in women with early stage breast cancer: Study

Exelixis reports updated interim data from trials of XL765 small molecule inhibitor of PI3K and mTOR

Exelixis reports updated interim data from trials of XL765 small molecule inhibitor of PI3K and mTOR

GRASP program reduces depression symptoms, boosts physical therapy results in stroke patients

GRASP program reduces depression symptoms, boosts physical therapy results in stroke patients

Tranzyme Pharma receives BioQuébec's 2010 Genesis Award for "Innovation"

Tranzyme Pharma receives BioQuébec's 2010 Genesis Award for "Innovation"

MD Anderson-led Phase III clinical study determines Sprycel superior to Gleevec as front-line therapy

MD Anderson-led Phase III clinical study determines Sprycel superior to Gleevec as front-line therapy

Telemedicine holds key to rehabilitation of people with stroke: Researcher

Telemedicine holds key to rehabilitation of people with stroke: Researcher

Kaiser Permanente earns perfect 100% rating on Healthcare Equality Index

Kaiser Permanente earns perfect 100% rating on Healthcare Equality Index

Study identifies potential link between Gilbert's Syndrome, childhood acute lymphoblastic leukemia

Study identifies potential link between Gilbert's Syndrome, childhood acute lymphoblastic leukemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.